{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:59:19Z","timestamp":1792040359966,"version":"4.4.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s12033-024-01190-x","type":"journal-article","created":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T13:01:51Z","timestamp":1717246911000},"page":"2138-2159","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Exploring the Targets and Molecular Mechanisms of Curcumin for the Treatment of Bladder Cancer Based on Network Pharmacology, Molecular Docking and Molecular Dynamics"],"prefix":"10.1007","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3614-9679","authenticated-orcid":false,"given":"Jun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujie","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingmin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,1]]},"reference":[{"issue":"1","key":"1190_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2021). Cancer statistics, 2021. CA: A Cancer Journal for Clinicians, 71(1), 7\u201333. https:\/\/doi.org\/10.3322\/caac.21654","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"10","key":"1190_CR2","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.medcli.2017.06.009","volume":"149","author":"RH Martinez Rodriguez","year":"2017","unstructured":"Martinez Rodriguez, R. H., Buisan Rueda, O., & Ibarz, L. (2017). Bladder cancer: Present and future. Medicina cl\u00ednica (Barc), 149(10), 449. https:\/\/doi.org\/10.1016\/j.medcli.2017.06.009","journal-title":"Medicina cl\u00ednica (Barc)"},{"issue":"6","key":"1190_CR3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"3","key":"1190_CR4","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.eururo.2017.05.040","volume":"72","author":"L Dyrskjot","year":"2017","unstructured":"Dyrskjot, L., Reinert, T., Algaba, F., et al. (2017). Prognostic impact of a 12-gene progression score in non-muscle-invasive bladder cancer: A prospective multicentre validation study. European Urology, 72(3), 461\u2013469. https:\/\/doi.org\/10.1016\/j.eururo.2017.05.040","journal-title":"European Urology"},{"issue":"4","key":"1190_CR5","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.eururo.2017.09.030","volume":"73","author":"M Abufaraj","year":"2018","unstructured":"Abufaraj, M., Dalbagni, G., Daneshmand, S., et al. (2018). The role of surgery in metastatic bladder cancer: A systematic review. European Urology, 73(4), 543\u2013557. https:\/\/doi.org\/10.1016\/j.eururo.2017.09.030","journal-title":"European Urology"},{"issue":"8","key":"1190_CR6","first-page":"507","volume":"96","author":"KC Degeorge","year":"2017","unstructured":"Degeorge, K. C., Holt, H. R., & Hodges, S. C. (2017). Bladder cancer: Diagnosis and treatment. American Family Physician, 96(8), 507\u2013514.","journal-title":"American Family Physician"},{"issue":"6","key":"1190_CR7","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/j.1464-410X.2011.10455.x","volume":"109","author":"AP Mitra","year":"2012","unstructured":"Mitra, A. P., Quinn, D. I., Dorff, T. B., et al. (2012). Factors influencing post-recurrence survival in bladder cancer following radical cystectomy. BJU International, 109(6), 846\u2013854. https:\/\/doi.org\/10.1111\/j.1464-410X.2011.10455.x","journal-title":"BJU International"},{"issue":"1","key":"1190_CR8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","volume":"79","author":"JA Witjes","year":"2021","unstructured":"Witjes, J. A., Bruins, H. M., Cathomas, R., et al. (2021). European association of urology guidelines on muscle-invasive and metastatic bladder cancer: Summary of the 2020 guidelines. European Urology, 79(1), 82\u2013104. https:\/\/doi.org\/10.1016\/j.eururo.2020.03.055","journal-title":"European Urology"},{"key":"1190_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13008-015-0012-z","volume":"6","author":"S Bose","year":"2015","unstructured":"Bose, S., Panda, A. K., Mukherjee, S., & Sa, G. (2015). Curcumin and tumor immune-editing: Resurrecting the immune system. Cell Division., 6, 10. https:\/\/doi.org\/10.1186\/s13008-015-0012-z","journal-title":"Cell Division."},{"key":"1190_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/nu11102376","author":"A Giordano","year":"2019","unstructured":"Giordano, A., & Tommonaro, G. (2019). Curcumin and cancer. Nutrients. https:\/\/doi.org\/10.3390\/nu11102376","journal-title":"Nutrients"},{"issue":"2","key":"1190_CR11","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3892\/ijo.2018.4423","volume":"53","author":"L Zhang","year":"2018","unstructured":"Zhang, L., Yang, G., Zhang, R., et al. (2018). Curcumin inhibits cell proliferation and motility via suppression of trop2 in bladder cancer cells. International Journal of Oncology, 53(2), 515\u2013526. https:\/\/doi.org\/10.3892\/ijo.2018.4423","journal-title":"International Journal of Oncology"},{"issue":"2","key":"1190_CR12","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.canlet.2008.01.041","volume":"264","author":"B Tian","year":"2008","unstructured":"Tian, B., Wang, Z., Zhao, Y., et al. (2008). Effects of curcumin on bladder cancer cells and development of urothelial tumors in a rat bladder carcinogenesis model. Cancer Letters, 264(2), 299\u2013308. https:\/\/doi.org\/10.1016\/j.canlet.2008.01.041","journal-title":"Cancer Letters"},{"issue":"4","key":"1190_CR13","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1124\/mol.111.072512","volume":"80","author":"HS Liu","year":"2011","unstructured":"Liu, H. S., Ke, C. S., Cheng, H. C., Huang, C. Y., & Su, C. L. (2011). Curcumin-induced mitotic spindle defect and cell cycle arrest in human bladder cancer cells occurs partly through inhibition of aurora a. Molecular Pharmacology, 80(4), 638\u2013646. https:\/\/doi.org\/10.1124\/mol.111.072512","journal-title":"Molecular Pharmacology"},{"issue":"5","key":"1190_CR14","first-page":"1225","volume":"15","author":"C Park","year":"2006","unstructured":"Park, C., Kim, G. Y., Kim, G. D., Choi, B. T., Park, Y. M., & Choi, Y. H. (2006). Induction of g2\/m arrest and inhibition of cyclooxygenase-2 activity by curcumin in human bladder cancer t24 cells. Oncology Reports, 15(5), 1225\u20131231.","journal-title":"Oncology Reports"},{"issue":"7","key":"1190_CR15","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1080\/1061186X.2017.1306535","volume":"25","author":"B Tian","year":"2017","unstructured":"Tian, B., Zhao, Y., Liang, T., et al. (2017). Curcumin inhibits urothelial tumor development by suppressing igf2 and igf2-mediated pi3k\/akt\/mtor signaling pathway. Journal of Drug Targeting, 25(7), 626\u2013636. https:\/\/doi.org\/10.1080\/1061186X.2017.1306535","journal-title":"Journal of Drug Targeting"},{"key":"1190_CR16","doi-asserted-by":"publisher","unstructured":"(2018) Editor's note: curcumin potentiates the antitumor effects of bacillus calmette-guerin against bladder cancer through the downregulation of nf-kappab and upregulation of trail receptors. Cancer Research, 78(17), 5182. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-1825.","DOI":"10.1158\/0008-5472.CAN-18-1825"},{"issue":"sup1","key":"1190_CR17","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1080\/10408398.2018.1501657","volume":"59","author":"Y Dai","year":"2019","unstructured":"Dai, Y., Chen, S. R., Chai, L., Zhao, J., Wang, Y., & Wang, Y. (2019). Overview of pharmacological activities of andrographis paniculata and its major compound andrographolide. Critical Reviews in Food Science and Nutrition, 59(sup1), S17\u2013S29. https:\/\/doi.org\/10.1080\/10408398.2018.1501657","journal-title":"Critical Reviews in Food Science and Nutrition"},{"key":"1190_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fphar.2019.00123","volume":"10","author":"R Zhang","year":"2019","unstructured":"Zhang, R., Zhu, X., Bai, H., & Ning, K. (2019). Network pharmacology databases for traditional chinese medicine: Review and assessment. Frontiers in Pharmacology., 10, 123. https:\/\/doi.org\/10.3389\/fphar.2019.00123","journal-title":"Frontiers in Pharmacology."},{"issue":"7","key":"1190_CR19","doi-asserted-by":"publisher","first-page":"13384","DOI":"10.3390\/molecules200713384","volume":"20","author":"LG Ferreira","year":"2015","unstructured":"Ferreira, L. G., Dos, S. R., Oliva, G., & Andricopulo, A. D. (2015). Molecular docking and structure-based drug design strategies. Molecules, 20(7), 13384\u201313421. https:\/\/doi.org\/10.3390\/molecules200713384","journal-title":"Molecules"},{"issue":"5","key":"1190_CR20","doi-asserted-by":"publisher","first-page":"501","DOI":"10.2174\/1389450119666181022153016","volume":"20","author":"S Saikia","year":"2019","unstructured":"Saikia, S., & Bordoloi, M. (2019). Molecular docking: Challenges, advances and its use in drug discovery perspective. Current Drug Targets, 20(5), 501\u2013521. https:\/\/doi.org\/10.2174\/1389450119666181022153016","journal-title":"Current Drug Targets"},{"issue":"18","key":"1190_CR21","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.3390\/ijms20184331","volume":"20","author":"L Pinzi","year":"2019","unstructured":"Pinzi, L., & Rastelli, G. (2019). Molecular docking: Shifting paradigms in drug discovery. International Journal of Molecular Sciences, 20(18), 4331. https:\/\/doi.org\/10.3390\/ijms20184331","journal-title":"International Journal of Molecular Sciences"},{"issue":"W1","key":"1190_CR22","doi-asserted-by":"publisher","first-page":"W356","DOI":"10.1093\/nar\/gkx374","volume":"45","author":"X Wang","year":"2017","unstructured":"Wang, X., Shen, Y., Wang, S., et al. (2017). Pharmmapper 2017 update: A web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Research, 45(W1), W356\u2013W360. https:\/\/doi.org\/10.1093\/nar\/gkx374","journal-title":"Nucleic Acids Research"},{"issue":"W1","key":"1190_CR23","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","volume":"47","author":"A Daina","year":"2019","unstructured":"Daina, A., Michielin, O., & Zoete, V. (2019). Swisstargetprediction: Updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Research, 47(W1), W357\u2013W364. https:\/\/doi.org\/10.1093\/nar\/gkz382","journal-title":"Nucleic Acids Research"},{"issue":"5","key":"1190_CR24","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s10822-016-9915-2","volume":"30","author":"ZJ Yao","year":"2016","unstructured":"Yao, Z. J., Dong, J., Che, Y. J., et al. (2016). Targetnet: A web service for predicting potential drug-target interaction profiling via multi-target sar models. Journal of Computer-Aided Molecular Design, 30(5), 413\u2013424. https:\/\/doi.org\/10.1007\/s10822-016-9915-2","journal-title":"Journal of Computer-Aided Molecular Design"},{"issue":"Web Server issu","key":"1190_CR25","doi-asserted-by":"publisher","first-page":"W26","DOI":"10.1093\/nar\/gku477","volume":"42","author":"J Nickel","year":"2014","unstructured":"Nickel, J., Gohlke, B. O., Erehman, J., et al. (2014). Superpred: Update on drug classification and target prediction. Nucleic Acids Research., 42(Web Server issue), W26\u2013W31. https:\/\/doi.org\/10.1093\/nar\/gku477","journal-title":"Nucleic Acids Research."},{"issue":"5","key":"1190_CR26","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1093\/nar\/gky092","volume":"46","author":"CT Uniprot","year":"2018","unstructured":"Uniprot, C. T. (2018). Uniprot: The universal protein knowledgebase. Nucleic Acids Research, 46(5), 2699. https:\/\/doi.org\/10.1093\/nar\/gky092","journal-title":"Nucleic Acids Research"},{"key":"1190_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cpbi.5","volume":"54","author":"G Stelzer","year":"2016","unstructured":"Stelzer, G., Rosen, N., Plaschkes, I., et al. (2016). The genecards suite: From gene data mining to disease genome sequence analyses. Current Protocols in Bioinformatics, 54, 1\u201330. https:\/\/doi.org\/10.1002\/cpbi.5","journal-title":"Current Protocols in Bioinformatics"},{"issue":"D1","key":"1190_CR28","doi-asserted-by":"publisher","first-page":"D1138","DOI":"10.1093\/nar\/gkaa891","volume":"49","author":"AP Davis","year":"2021","unstructured":"Davis, A. P., Grondin, C. J., Johnson, R. J., et al. (2021). Comparative toxicogenomics database (ctd): Update 2021. Nucleic Acids Research, 49(D1), D1138\u2013D1143. https:\/\/doi.org\/10.1093\/nar\/gkaa891","journal-title":"Nucleic Acids Research"},{"issue":"D1","key":"1190_CR29","doi-asserted-by":"publisher","first-page":"D845","DOI":"10.1093\/nar\/gkz1021","volume":"48","author":"J Pinero","year":"2020","unstructured":"Pinero, J., Ramirez-Anguita, J. M., Sauch-Pitarch, J., et al. (2020). The disgenet knowledge platform for disease genomics: 2019 update. Nucleic Acids Research, 48(D1), D845\u2013D855. https:\/\/doi.org\/10.1093\/nar\/gkz1021","journal-title":"Nucleic Acids Research"},{"issue":"D1","key":"1190_CR30","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart, D. S., Feunang, Y. D., Guo, A. C., et al. (2018). Drugbank 5.0: A major update to the drugbank database for 2018. Nucleic Acids Research, 46(D1), D1074\u2013D1082. https:\/\/doi.org\/10.1093\/nar\/gkx1037","journal-title":"Nucleic Acids Research"},{"issue":"3","key":"1190_CR31","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/cpt.2350","volume":"110","author":"M Whirl-Carrillo","year":"2021","unstructured":"Whirl-Carrillo, M., Huddart, R., Gong, L., et al. (2021). An evidence-based framework for evaluating pharmacogenomics knowledge for personalized medicine. Clinical Pharmacology and Therapeutics, 110(3), 563\u2013572. https:\/\/doi.org\/10.1002\/cpt.2350","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"D1","key":"1190_CR32","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M., & Ishiguro-Watanabe, M. (2023). Kegg for taxonomy-based analysis of pathways and genomes. Nucleic Acids Research, 51(D1), D587\u2013D592. https:\/\/doi.org\/10.1093\/nar\/gkac963","journal-title":"Nucleic Acids Research"},{"issue":"W1","key":"1190_CR33","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman, B. T., Hao, M., Qiu, J., et al. (2022). David: A web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Research, 50(W1), W216\u2013W221. https:\/\/doi.org\/10.1093\/nar\/gkac194","journal-title":"Nucleic Acids Research"},{"issue":"5","key":"1190_CR34","doi-asserted-by":"publisher","first-page":"372","DOI":"10.2174\/138955710791330891","volume":"10","author":"S Padhye","year":"2010","unstructured":"Padhye, S., Chavan, D., Pandey, S., Deshpande, J., Swamy, K. V., & Sarkar, F. H. (2010). Perspectives on chemopreventive and therapeutic potential of curcumin analogs in medicinal chemistry. Mini-Reviews in Medicinal Chemistry, 10(5), 372\u2013387. https:\/\/doi.org\/10.2174\/138955710791330891","journal-title":"Mini-Reviews in Medicinal Chemistry"},{"issue":"12","key":"1190_CR35","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.3390\/molecules25122791","volume":"25","author":"B Zheng","year":"2020","unstructured":"Zheng, B., & Mcclements, D. J. (2020). Formulation of more efficacious curcumin delivery systems using colloid science: Enhanced solubility, stability, and bioavailability. Molecules, 25(12), 2791. https:\/\/doi.org\/10.3390\/molecules25122791","journal-title":"Molecules"},{"issue":"4","key":"1190_CR36","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/cancers9040030","volume":"9","author":"MC De Santis","year":"2017","unstructured":"De Santis, M. C., Sala, V., Martini, M., Ferrero, G. B., & Hirsch, E. (2017). Pi3k signaling in tissue hyper-proliferation: From overgrowth syndromes to kidney cysts. Cancers, 9(4), 30. https:\/\/doi.org\/10.3390\/cancers9040030","journal-title":"Cancers"},{"issue":"7","key":"1190_CR37","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1158\/0008-5472.CAN-11-3132","volume":"72","author":"DJ Mulholland","year":"2012","unstructured":"Mulholland, D. J., Kobayashi, N., Ruscetti, M., et al. (2012). Pten loss and ras\/mapk activation cooperate to promote emt and metastasis initiated from prostate cancer stem\/progenitor cells. Cancer Research, 72(7), 1878\u20131889. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3132","journal-title":"Cancer Research"},{"issue":"1","key":"1190_CR38","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13046-018-0699-1","volume":"37","author":"D Li","year":"2018","unstructured":"Li, D., Zhang, Y., Zhang, H., et al. (2018). Cadm2, as a new target of mir-10b, promotes tumor metastasis through fak\/akt pathway in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research, 37(1), 46. https:\/\/doi.org\/10.1186\/s13046-018-0699-1","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"3\u20134","key":"1190_CR39","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10555-009-9198-3","volume":"28","author":"MA Knowles","year":"2009","unstructured":"Knowles, M. A., Platt, F. M., Ross, R. L., & Hurst, C. D. (2009). Phosphatidylinositol 3-kinase (pi3k) pathway activation in bladder cancer. Cancer and Metastasis Reviews, 28(3\u20134), 305\u2013316. https:\/\/doi.org\/10.1007\/s10555-009-9198-3","journal-title":"Cancer and Metastasis Reviews"},{"issue":"1","key":"1190_CR40","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3892\/or.2018.6421","volume":"40","author":"WL Li","year":"2018","unstructured":"Li, W. L., Yu, H. Y., Zhang, X. J., Ke, M., & Hong, T. (2018). Purple sweet potato anthocyanin exerts antitumor effect in bladder cancer. Oncology Reports, 40(1), 73\u201382. https:\/\/doi.org\/10.3892\/or.2018.6421","journal-title":"Oncology Reports"},{"issue":"3","key":"1190_CR41","doi-asserted-by":"publisher","first-page":"113","DOI":"10.4021\/wjon335w","volume":"2","author":"J Wang","year":"2011","unstructured":"Wang, J., Wang, Z., Wang, H., Zhao, J., & Zhang, Z. (2011). Curcumin induces apoptosis in ej bladder cancer cells via modulating c-myc and pi3k\/akt signaling pathway. World Journal of Clinical Oncology., 2(3), 113\u2013122. https:\/\/doi.org\/10.4021\/wjon335w","journal-title":"World Journal of Clinical Oncology."},{"issue":"9","key":"1190_CR42","doi-asserted-by":"publisher","first-page":"11541","DOI":"10.1007\/s13277-016-5083-1","volume":"37","author":"R Pinto-Leite","year":"2016","unstructured":"Pinto-Leite, R., Arantes-Rodrigues, R., Sousa, N., Oliveira, P. A., & Santos, L. (2016). Mtor inhibitors in urinary bladder cancer. Tumour Biology, 37(9), 11541\u201311551. https:\/\/doi.org\/10.1007\/s13277-016-5083-1","journal-title":"Tumour Biology"},{"issue":"8","key":"1190_CR43","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.bbamcr.2006.10.005","volume":"1773","author":"YD Shaul","year":"2007","unstructured":"Shaul, Y. D., & Seger, R. (2007). The mek\/erk cascade: From signaling specificity to diverse functions. Biochimica et Biophysica Acta, 1773(8), 1213\u20131226. https:\/\/doi.org\/10.1016\/j.bbamcr.2006.10.005","journal-title":"Biochimica et Biophysica Acta"},{"issue":"8","key":"1190_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23399","volume":"37","author":"Y Zhi","year":"2023","unstructured":"Zhi, Y., Cai, C., Xu, T., et al. (2023). Silencing of fgf6 hampers aerobic glycolysis and angiogenesis in bladder cancer by regulating pi3k\/akt and mapk signaling pathways. Journal of Biochemical and Molecular Toxicology, 37(8), e23399. https:\/\/doi.org\/10.1002\/jbt.23399","journal-title":"Journal of Biochemical and Molecular Toxicology"},{"issue":"6","key":"1190_CR45","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41419-023-05882-1","volume":"14","author":"L Yang","year":"2023","unstructured":"Yang, L., Huang, W., Bai, X., et al. (2023). Androgen dihydrotestosterone promotes bladder cancer cell proliferation and invasion via eppk1-mediated mapk\/jup signaling. Cell Death & Disease, 14(6), 363. https:\/\/doi.org\/10.1038\/s41419-023-05882-1","journal-title":"Cell Death & Disease"},{"issue":"22","key":"1190_CR46","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1200\/JCO.2005.05.1771","volume":"24","author":"S Hernandez","year":"2006","unstructured":"Hernandez, S., Lopez-Knowles, E., Lloreta, J., et al. (2006). Prospective study of fgfr3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas. Journal of Clinical Oncology, 24(22), 3664\u20133671. https:\/\/doi.org\/10.1200\/JCO.2005.05.1771","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"1190_CR47","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.3390\/ijms24021776","volume":"24","author":"GK Huang","year":"2023","unstructured":"Huang, G. K., Huang, C. C., Kang, C. H., et al. (2023). Genetic interference of fgfr3 impedes invasion of upper tract urothelial carcinoma cells by alleviating ras\/mapk signal activity. International Journal of Molecular Sciences, 24(2), 1776. https:\/\/doi.org\/10.3390\/ijms24021776","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"1190_CR48","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13045-022-01311-6","volume":"15","author":"K Shi","year":"2022","unstructured":"Shi, K., Wang, G., Pei, J., et al. (2022). Emerging strategies to overcome resistance to third-generation egfr inhibitors. Journal of Hematology & Oncology, 15(1), 94. https:\/\/doi.org\/10.1186\/s13045-022-01311-6","journal-title":"Journal of Hematology & Oncology"},{"issue":"10","key":"1190_CR49","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/35096075","volume":"2","author":"P Cohen","year":"2001","unstructured":"Cohen, P., & Frame, S. (2001). The renaissance of gsk3. Nature Reviews Molecular Cell Biology, 2(10), 769\u2013776. https:\/\/doi.org\/10.1038\/35096075","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"7","key":"1190_CR50","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/s41388-020-01534-2","volume":"40","author":"M Rose","year":"2021","unstructured":"Rose, M., Maurer, A., Wirtz, J., et al. (2021). Correction: Egfr activity addiction facilitates anti-erbb based combination treatment of squamous bladder cancer. Oncogene, 40(7), 1390. https:\/\/doi.org\/10.1038\/s41388-020-01534-2","journal-title":"Oncogene"},{"issue":"7","key":"1190_CR51","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1084\/jem.20090207","volume":"206","author":"L Wang","year":"2009","unstructured":"Wang, L., Yi, T., Kortylewski, M., Pardoll, D. M., Zeng, D., & Yu, H. (2009). Il-17 can promote tumor growth through an il-6-stat3 signaling pathway. Journal of Experimental Medicine, 206(7), 1457\u20131464. https:\/\/doi.org\/10.1084\/jem.20090207","journal-title":"Journal of Experimental Medicine"},{"key":"1190_CR52","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.bbrc.2022.02.053","volume":"602","author":"L Wang","year":"2022","unstructured":"Wang, L., Hu, C., Zhao, Y., & Hu, X. (2022). Novel smac mimetic astx660 (tolinapant) and tnf-alpha synergistically induce necroptosis in bladder cancer cells in vitro upon apoptosis inhibition. Biochemical and Biophysical Research Communications, 602, 8\u201314. https:\/\/doi.org\/10.1016\/j.bbrc.2022.02.053","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"5","key":"1190_CR53","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1080\/21645515.2019.1571892","volume":"15","author":"Y Jiang","year":"2019","unstructured":"Jiang, Y., Chen, M., Nie, H., & Yuan, Y. (2019). Pd-1 and pd-l1 in cancer immunotherapy: Clinical implications and future considerations. Human Vaccines Immunother., 15(5), 1111\u20131122. https:\/\/doi.org\/10.1080\/21645515.2019.1571892","journal-title":"Human Vaccines Immunother."},{"issue":"6","key":"1190_CR54","doi-asserted-by":"publisher","first-page":"6869","DOI":"10.3892\/ol.2019.11023","volume":"18","author":"CJ Cho","year":"2019","unstructured":"Cho, C. J., Yang, C. W., Wu, C. L., et al. (2019). The modulation study of multiple drug resistance in bladder cancer by curcumin and resveratrol. Oncology Letters, 18(6), 6869\u20136876. https:\/\/doi.org\/10.3892\/ol.2019.11023","journal-title":"Oncology Letters"},{"issue":"5","key":"1190_CR55","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.jbiosc.2012.11.007","volume":"115","author":"M Ueki","year":"2013","unstructured":"Ueki, M., Ueno, M., Morishita, J., & Maekawa, N. (2013). Curcumin ameliorates cisplatin-induced nephrotoxicity by inhibiting renal inflammation in mice. Journal of Bioscience and Bioengineering, 115(5), 547\u2013551. https:\/\/doi.org\/10.1016\/j.jbiosc.2012.11.007","journal-title":"Journal of Bioscience and Bioengineering"},{"key":"1190_CR56","doi-asserted-by":"publisher","first-page":"800967","DOI":"10.3389\/fcell.2021.800967","volume":"9","author":"H Li","year":"2021","unstructured":"Li, H., Liu, S., Li, C., Xiao, Z., Hu, J., & Zhao, C. (2021). Tnf family-based signature predicts prognosis, tumor microenvironment, and molecular subtypes in bladder carcinoma. Frontiers in Cell and Developmental Biology, 9, 800967. https:\/\/doi.org\/10.3389\/fcell.2021.800967","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"1190_CR57","doi-asserted-by":"publisher","first-page":"2901189","DOI":"10.1155\/2022\/2901189","volume":"2022","author":"X Wei","year":"2022","unstructured":"Wei, X., Wang, J., Liu, H., Fan, W., & Guo, G. (2022). Preoperative nutritional risk assessment for predicting complications after radical cystectomy plus urinary diversion for bladder cancer. Emergency Medicine International, 2022, 2901189. https:\/\/doi.org\/10.1155\/2022\/2901189","journal-title":"Emergency Medicine International"},{"issue":"9","key":"1190_CR58","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1016\/j.cellsig.2013.05.001","volume":"25","author":"PC Moschella","year":"2013","unstructured":"Moschella, P. C., Mckillop, J., Pleasant, D. L., Harston, R. K., Balasubramanian, S., & Kuppuswamy, D. (2013). Mtor complex 2 mediates akt phosphorylation that requires pkcepsilon in adult cardiac muscle cells. Cellular signaling, 25(9), 1904\u20131912. https:\/\/doi.org\/10.1016\/j.cellsig.2013.05.001","journal-title":"Cellular signaling"},{"key":"1190_CR59","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ejphar.2015.06.059","volume":"764","author":"H Sabbineni","year":"2015","unstructured":"Sabbineni, H., Alwhaibi, A., Goc, A., Gao, F., Pruitt, A., & Somanath, P. R. (2015). Genetic deletion and pharmacological inhibition of akt1 isoform attenuates bladder cancer cell proliferation, motility and invasion. European Journal of Pharmacology., 764, 208\u2013214. https:\/\/doi.org\/10.1016\/j.ejphar.2015.06.059","journal-title":"European Journal of Pharmacology."},{"key":"1190_CR60","doi-asserted-by":"publisher","DOI":"10.3892\/or.2021.8244","author":"X Gao","year":"2022","unstructured":"Gao, X., Liu, J., Fan, D., et al. (2022). Berberine enhances gemcitabine-induced cytotoxicity in bladder cancer by downregulating rad51 expression through inactivating the pi3k\/akt pathway. Oncology Report. https:\/\/doi.org\/10.3892\/or.2021.8244","journal-title":"Oncology Report."},{"issue":"14","key":"1190_CR61","doi-asserted-by":"publisher","first-page":"11852","DOI":"10.3390\/ijms241411852","volume":"24","author":"CY Hsu","year":"2023","unstructured":"Hsu, C. Y., Yang, W. T., Lin, J. H., et al. (2023). Sertindole, an antipsychotic drug, curbs the stat3\/bcl-xl axis to elicit human bladder cancer cell apoptosis in vitro. International Journal of Molecular Sciences, 24(14), 11852. https:\/\/doi.org\/10.3390\/ijms241411852","journal-title":"International Journal of Molecular Sciences"},{"issue":"12","key":"1190_CR62","doi-asserted-by":"publisher","first-page":"4326","DOI":"10.1111\/cas.14675","volume":"111","author":"T Hayakawa","year":"2020","unstructured":"Hayakawa, T., Yaguchi, T., & Kawakami, Y. (2020). Enhanced anti-tumor effects of the pd-1 blockade combined with a highly absorptive form of curcumin targeting stat3. Cancer Science, 111(12), 4326\u20134335. https:\/\/doi.org\/10.1111\/cas.14675","journal-title":"Cancer Science"},{"issue":"1","key":"1190_CR63","doi-asserted-by":"publisher","first-page":"167","DOI":"10.21873\/anticanres.16146","volume":"43","author":"M Hashimoto","year":"2023","unstructured":"Hashimoto, M., Fujita, K., Tomiyama, E., et al. (2023). Immunohistochemical analysis of her2, egfr, and nectin-4 expression in upper urinary tract urothelial carcinoma. Anticancer Research, 43(1), 167\u2013174. https:\/\/doi.org\/10.21873\/anticanres.16146","journal-title":"Anticancer Research"},{"issue":"7","key":"1190_CR64","doi-asserted-by":"publisher","first-page":"3966","DOI":"10.3390\/ijms23073966","volume":"23","author":"M Saeed","year":"2022","unstructured":"Saeed, M., Yucer, R., Dawood, M., et al. (2022). In silico and in vitro screening of 50 curcumin compounds as egfr and nf-kappab inhibitors. International Journal of Molecular Sciences, 23(7), 3966. https:\/\/doi.org\/10.3390\/ijms23073966","journal-title":"International Journal of Molecular Sciences"},{"key":"1190_CR65","doi-asserted-by":"publisher","first-page":"776808","DOI":"10.3389\/fmolb.2022.776808","volume":"9","author":"Z Zhou","year":"2022","unstructured":"Zhou, Z., Xu, S., Jiang, L., Tan, Z., & Wang, J. (2022). A systematic pan-cancer analysis of casp3 as a potential target for immunotherapy. Frontiers in Molecular Biosciences., 9, 776808. https:\/\/doi.org\/10.3389\/fmolb.2022.776808","journal-title":"Frontiers in Molecular Biosciences."},{"issue":"2","key":"1190_CR66","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3390\/md21020073","volume":"21","author":"CH Chang","year":"2023","unstructured":"Chang, C. H., Lin, B. J., Chen, C. H., et al. (2023). Stellettin b induces cell death in bladder cancer via activating the autophagy\/dapk2\/apoptosis signaling cascade. Marine Drugs, 21(2), 73. https:\/\/doi.org\/10.3390\/md21020073","journal-title":"Marine Drugs"},{"issue":"1","key":"1190_CR67","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.3892\/ol.2017.6205","volume":"14","author":"J Shi","year":"2017","unstructured":"Shi, J., Zhang, X., Shi, T., & Li, H. (2017). Antitumor effects of curcumin in human bladder cancer in vitro. Oncology Letters, 14(1), 1157\u20131161. https:\/\/doi.org\/10.3892\/ol.2017.6205","journal-title":"Oncology Letters"},{"issue":"6","key":"1190_CR68","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3390\/jpm11060473","volume":"11","author":"H Jutte","year":"2021","unstructured":"Jutte, H., Reike, M., Wirtz, R. M., et al. (2021). Krt20, krt5, esr1 and erbb2 expression can predict pathologic outcome in patients undergoing neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer. Journal of Personalized Medicine, 11(6), 473. https:\/\/doi.org\/10.3390\/jpm11060473","journal-title":"Journal of Personalized Medicine"},{"issue":"8","key":"1190_CR69","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1158\/1078-0432.CCR-18-3121","volume":"25","author":"SG Zhao","year":"2019","unstructured":"Zhao, S. G., Chen, W. S., Das, R., et al. (2019). Clinical and genomic implications of luminal and basal subtypes across carcinomas. Clinical Cancer Research, 25(8), 2450\u20132457. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-3121","journal-title":"Clinical Cancer Research"},{"issue":"5","key":"1190_CR70","doi-asserted-by":"publisher","first-page":"343","DOI":"10.5455\/medarh.2022.76.343-347","volume":"76","author":"B Daryanto","year":"2022","unstructured":"Daryanto, B., Wibowo, E., Seputra, K. P., & Yudhanto, H. S. (2022). Effect of conjugated linoleic acid (cla) supplementation on expression of b-cell lymphoma-2 (bcl-2) in the bladder epithelium of wistar (rattus norvegicus) rats exposed to cigarette smoke. Medical Archives, 76(5), 343\u2013347. https:\/\/doi.org\/10.5455\/medarh.2022.76.343-347","journal-title":"Medical Archives"},{"key":"1190_CR71","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.167270","author":"W Dunker","year":"2023","unstructured":"Dunker, W., Zaver, S. A., Pineda, J., Howard, C. J., Bradley, R. K., & Woodward, J. J. (2023). The proto-oncogene src phosphorylates cgas to inhibit an antitumor immune response. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.167270","journal-title":"JCI Insight"},{"issue":"10","key":"1190_CR72","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1158\/1940-6207.CAPR-11-0267","volume":"4","author":"S Saini","year":"2011","unstructured":"Saini, S., Arora, S., Majid, S., et al. (2011). Curcumin modulates microrna-203-mediated regulation of the src-akt axis in bladder cancer. Cancer Prevention Research, 4(10), 1698\u20131709. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-11-0267","journal-title":"Cancer Prevention Research"},{"key":"1190_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106654","volume":"188","author":"Q Wu","year":"2023","unstructured":"Wu, Q., Chen, P., Li, J., Lin, Z., Zhang, Q., & Kwok, H. F. (2023). Inhibition of bladder cancer growth with homoharringtonine by inactivating integrin alpha5\/beta1-fak\/src axis: A novel strategy for drug application. Pharmacological Research., 188, 106654. https:\/\/doi.org\/10.1016\/j.phrs.2023.106654","journal-title":"Pharmacological Research."},{"issue":"11","key":"1190_CR74","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1002\/tox.23332","volume":"36","author":"CC Kao","year":"2021","unstructured":"Kao, C. C., Cheng, Y. C., Yang, M. H., et al. (2021). Demethoxycurcumin induces apoptosis in her2 overexpressing bladder cancer cells through degradation of her2 and inhibiting the pi3k\/akt pathway. Environmental Toxicology, 36(11), 2186\u20132195. https:\/\/doi.org\/10.1002\/tox.23332","journal-title":"Environmental Toxicology"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01190-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-024-01190-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01190-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T01:03:04Z","timestamp":1744246984000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-024-01190-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,1]]},"references-count":74,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["1190"],"URL":"https:\/\/doi.org\/10.1007\/s12033-024-01190-x","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,1]]},"assertion":[{"value":"24 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}